Entering text into the input field will update the search result below

Biogen yet to convince payors for new Alzheimer’s drug, Bloomberg survey reveals

Nov. 18, 2021 11:57 AM ETBiogen Inc. (BIIB) Stock, ESALY StockCVS, UNH, ELV, CNC, HUMBy: Dulan Lokuwithana, SA News Editor6 Comments

Alzheimers Concept Horizontal

travellinglight/iStock via Getty Images

  • Many insurers continue to hesitate in providing coverage for Aduhelm, the recently approved medication developed by Biogen (NASDAQ:BIIB) and Eisai (OTCPK:ESALY) for Alzheimer’s disease, Bloomberg reported citing a News Survey.
  • In the study, none of the 25 large

Recommended For You

Related Stocks

SymbolLast Price% Chg
BIIB
--
ESALY
--